• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION VERIFY ENHANCED; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION VERIFY ENHANCED; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCON Back to Search Results
Model Number 353101
Medical Device Problem Codes Break (1069); Migration or Expulsion of Device (1395)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/22/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Continuation of d10: product id 978b128 lot# va2xft8 serial# implanted: (b)(6) 2024 explanted: (b)(6) 2024 product type lead section d information references the main component of the system.Other relevant device(s) are: product id: 978b128, serial/lot #: (b)(6), ubd: 11-sep-2025, udi#: (b)(4) h3: analysis results were not available at the time of this report.A follow-up report will be sent when analysis is completed.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
Information was received from a healthcare provider regarding a trial patient who was using an external neurostimulator (ens) for fecal incontinence.Their trial start date was (b)(6) 2024.It was reported that the patient felt the stimulation throughout the entire trial.However, on (b)(6) 2024, the date of the stage 2 trial when the physician opened up the pocket and the lead was exposed; the lead had migrated completely out of the foramen.Hcp reported the lead was broken; the tines were not effective and did not hold the lead wire in place.The issue has been resolved.
 
Additional Manufacturer Narrative
Continuation of d10: product id: 978b128, lot# va2xft8, implanted: (b)(6) 2024, explanted: (b)(6) 2024, product type: lead.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
Additional information was received from a manufacturer representative (rep).The rep reported that the cause might be due to potential patient movement during the trial leading to migration and that the lead was not broken, the tines may have been weak, the lead was intact.
 
Additional Manufacturer Narrative
H3: analysis of the lead (lot# va2xft8) revealed, that the returned device passed all functional testing.No anomalies were identified.Continuation of d10: product id: 978b128, lot#: va2xft8, implanted: (b)(6) 2024, explanted: (b)(6) 2024, product type: lead.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank, because the information is currently, unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERIFY ENHANCED
Common Device Name
STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCON
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 1200
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 1200
Manufacturer Contact
glen belmer
7000 central avenue ne rcw215
minneapolis, MN 55432
6122713209
MDR Report Key19260724
Report Number2182207-2024-02505
Device Sequence Number14095492
Product Code EZW
UDI-Device Identifier00763000344573
UDI-Public00763000344573
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
P970004
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 07/03/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number353101
Device Catalogue Number353101
Was Device Available for Evaluation? No
Date Returned to Manufacturer04/30/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/22/2024
Supplement Date Received by Manufacturer05/08/2024
06/17/2024
Initial Report FDA Received Date05/07/2024
Supplement Report FDA Received Date05/28/2024
07/03/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured12/08/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age85 YR
Patient SexFemale
-
-